The DOI matches its Crossref record; 226 of the 227 references it cites were found in a registry or an index.
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation
Open accessAbstract
Alzheimer disease (AD) is the most common form of dementia among the elderly and is characterized by progressive loss of memory and cognition. These clinical features are due in part to the increase of reactive oxygen and nitrogen species that mediate neurotoxic effects. The up-regulation of the heme oxygenase-1/biliverdin reductase-A (HO-1/BVR-A) system is one of the earlier events in the adaptive response to stress. HO-1/BVR-A reduces the intracellular levels of pro-oxidant heme and generates equimolar amounts of the free radical scavengers biliverdin-IX alpha (BV)/bilirubin-IX alpha (BR) as well as the pleiotropic gaseous neuromodulator carbon monoxide (CO) and ferrous iron. Two main and opposite hypotheses for a role of the HO-1/BVR-A system in AD propose that this system mediates neurotoxic and neuroprotective effects, respectively. This apparent controversy was mainly due to the fact that for over about 20years HO-1 was the only player on which all the analyses were focused, excluding the other important and essential component of the entire system, BVR. Following studies from the Butterfield laboratory that reported alterations in BVR activity along with decreased phosphorylation and increased oxidative/nitrosative post-translational modifications in the brain of subjects with AD and amnestic mild cognitive impairment (MCI) subjects, a debate was opened on the real pathophysiological and clinical significance of BVR-A. In this paper we provide a review of the main discoveries about the HO/BVR system in AD and MCI, and propose a mechanism that reconciles these two hypotheses noted above of neurotoxic and the neuroprotective aspects of this important stress responsive system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It also suggests that atorvastatin, although not a direct antioxidant and not able to cross the BBB, leads to antioxidant-like effects in brain100.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [100]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BVR-A, in addition to being a reductase, is a kinase that can phosphorylate insulin receptor substrate-1100.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Both HO-1 and BVR-A are oxidatively damaged in aMCI and AD brain100.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [100]
The cited source says what the claim attributes to it.
In the citing paper
“BVR-A is nitrosatively modified and dysfunctional in AD and MCI brain100, and its impairment promotes insulin resistance101.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [100]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recently, intranasal treatment of a 3 X Tg mice model of AD with insulin showed a significant reduction of brain nitrosative stress, tau phosphorylation, and Aβ oligomers coupled to improved cognition, and these effects were dependent on the activity of biliverdin reductase-A (BVR-A)99,100.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [100]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Bilirubin Is an Antioxidant of Possible Physiological Importance
Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., & Ames, B. N. (1987) · Science · doi:10.1126/science.3029864 · Cited by 3,502
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cb3e25 · Cited by 2,572
THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases
Maines, M. D. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.517 · Cited by 2,489
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
Flagged first, then by citations
1 of the 227 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Di Domenico, 2013, Biliverdin reductase-A correlates with iNOS in atorvastatin treated aged canine brain, Neural. Reg. Res., 8, 1925
Cited by
Sorted by citations
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Self-citationProgrammed Cell-Death by Ferroptosis: Antioxidants as Mitigators
Kajarabille, N., & Latunde-Dada, G. O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194968 · Cited by 687
Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526
Self-citationVerdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 509
Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402
Self-citationButterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403
Self-citationInsulin and Insulin Resistance in Alzheimer’s Disease
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189987 · Cited by 414
Metal Ions in Alzheimer’s Disease: A Key Role or Not?
Liu, Y., Nguyen, M., Robert, A., & Meunier, B. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00248 · Cited by 353
de la Monte, S. M. (2017) · Drugs · doi:10.1007/s40265-016-0674-0 · Cited by 331
The role of type 2 diabetes in neurodegeneration
Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 290
Di Domenico, F., Tramutola, A., & Butterfield, D. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.490 · Cited by 253
Self-citationMancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232
Self-citationA Novel Perspective on the Biology of Bilirubin in Health and Disease
Gazzin, S., Vı́tek, L., Watchko, J. F., Shapiro, S. M., & Tiribelli, C. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.004 · Cited by 215
Robert, A., Liu, Y., Nguyen, M., & Meunier, B. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00119 · Cited by 212
Hooda, J., Shah, A. N., & Li, Z. (2014) · Nutrients · doi:10.3390/nu6031080 · Cited by 222
Homocysteine and age-associated disorders
Ostrakhovitch, E. A., & TABIBZADEH, S. S. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.010 · Cited by 182
Barone, E., Domenico, F. D., Marzia Perluigi, A., & Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.006 · Cited by 182
Self-citationWagner, K., Wallner, M., Mölzer, C., Gazzin, S., Bulmer, A. C., Tiribelli, C., & Vítek, L. (2015) · Clinical Science · doi:10.1042/cs20140566 · Cited by 171
Fasae, K. D., Abolaji, A. O., Faloye, T. R., Odunsi, A., Oyetayo, B. O., Enya, J. I., Rotimi, J. A., Akinyemi, R., Whitworth, A. J., & Aschner, M. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126779 · Cited by 161
Hansen, T. W. R., Wong, R. J., & Stevenson, D. K. (2020) · Physiological Reviews · doi:10.1152/physrev.00004.2019 · Cited by 157
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases
Dattilo, S., Mancuso, C., Koverech, G., Mauro, P. D., Ontario, M. L., Petralia, C. C. T., Petralia, A., Maiolino, L., Serra, A., Calabrese, E. J., et al. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0046-8 · Cited by 140
Self-citationButterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126
Self-citationYu, L., Wang, S., Chen, X., Yang, H., Li, X., Xu, Y., & Zhu, X. (2015) · Life Sciences · doi:10.1016/j.lfs.2014.11.021 · Cited by 127
Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
Ríos, J. A., Cisternas, P., Arrese, M. A., Salesa Barja, Y., & Inestrosa, N. C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.004 · Cited by 107
Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes
Rochette, L., Zeller, M., Cottin, Y., & Vergely, C. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.11.005 · Cited by 103
Barone, E., Di Domenico, F., Cassano, T., Arena, A., Tramutola, A., Lavecchia, M. A., Coccia, R., Butterfield, D. A., & Perluigi, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.012 · Cited by 100
Self-citationCobourne-Duval, M. K., Taka, E., Mendonca, P., & Soliman, K. F. A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.04.018 · Cited by 94
Research Progress on Alzheimer's Disease and Resveratrol
Yan, Y., Yang, H., Xie, Y., Ding, Y., Kong, D., & Yu, H. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03007-0 · Cited by 93
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
Barone, E., Tramutola, A., Triani, F., Calcagnini, S., Di Domenico, F., Ripoli, C., Gaetani, S., Grassi, C., Butterfield, D. A., Cassano, T., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1231-5 · Cited by 86
Self-citationGou, L., Zhao, L., Song, W., Wang, L., Liu, J., Zhang, H., Huang, Y., Lau, C. W., Yao, X., Tian, X. Y., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7005 · Cited by 86
Heme oxygenase in neuroprotection: from mechanisms to therapeutic implications
Chen, J. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0046 · Cited by 91
Matsuda, S., Nakagawa, Y., Tsuji, A., Kitagishi, Y., Nakanishi, A., & Murai, T. (2018) · Diseases · doi:10.3390/diseases6020028 · Cited by 86
Antognelli, C., Trapani, E., Monache, S. D., Perrelli, A., Daga, M., Pizzimenti, S., Barrera, G., Cassoni, P., Angelucci, A., Trabalzini, L., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.11.014 · Cited by 81
Barone, E., Domenico, F. D., & Butterfield, D. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.030 · Cited by 83
Self-citationDi Domenico, F., Pupo, G., Mancuso, C., Barone, E., Paolini, F., Arena, A., Blarzino, C., Schmitt, F. A., Head, E., Butterfield, D. A., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141254 · Cited by 75
Self-citationPentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73
Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder
Kshirsagar, V., Thingore, C., & Juvekar, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00622-2 · Cited by 66
Wang, Y., Liao, J., Luo, Y., Li, M., Su, X., Yu, B., Teng, J., Wang, H., & Lv, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043257 · Cited by 62
A Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders
Schipper, H. M., & Song, W. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16035400 · Cited by 57
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
Sharma, N. K., Tramutola, A., Lanzillotta, C., Arena, A., Blarzino, C., Cassano, T., Butterfield, D. A., Domenico, F. D., Marzia Perluigi, A., & Barone, E. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.003 · Cited by 59
Self-citationPerspectives on Oxidative Stress in Alzheimer’s Disease and Predictions of Future Research Emphases
Butterfield, D. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179912 · Cited by 57
Self-citationDisturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism
Barone, E., Arena, A., Head, E., Butterfield, D. A., & Marzia Perluigi, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.009 · Cited by 55
Self-citationSalerno, L., Floresta, G., Ciaffaglione, V., Gentile, D., Margani, F., Turnaturi, R., Rescifina, A., & Pittalà, V. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.02.027 · Cited by 54
Nitric Oxide Homeostasis in Neurodegenerative Diseases
Hannibal, L. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921101250 · Cited by 53
The Pathophysiology of Heme in the Brain
Gozzelino, R. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921103304 · Cited by 52
Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer’s Disease?
Murphy, K. E., & Park, J. C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061168 · Cited by 49
Regenerative effects of heme oxygenase metabolites on neuroinflammatory diseases
Lee, H., & Choi, Y. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010078 · Cited by 47
Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
Marrano, N., Biondi, G., Borrelli, A., Rella, M., Zambetta, T., Gioia, L. D., Caporusso, M., Logroscino, G., Perrini, S., Giorgino, F., et al. (2023) · Biomolecules · doi:10.3390/biom13010183 · Cited by 44
Marzia Perluigi, A., Tramutola, A., Pagnotta, S. E., Barone, E., & Butterfield, D. A. (2020) · Antioxidants · doi:10.3390/antiox9090779 · Cited by 44
Self-citationLópez‐Pingarrón, L., Almeida, H., Soria-Aznar, M., Reyes-Gonzales, M. C., Rodríguez-Moratinos, A. B., Muñoz‐Hoyos, A., & García, J. J. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45040232 · Cited by 40
Increased bilirubin levels in de novo Parkinson's disease
Moccia, M., Picillo, M., Erro, R., Longo, K., Amboni, M., Santangelo, G., Palladino, R., Allocca, R., Caporale, O., Triassi, M., et al. (2015) · European Journal of Neurology · doi:10.1111/ene.12688 · Cited by 41
Triplett, J. C., Swomley, A. M., Cai, J., Klein, J. B., & Butterfield, D. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150417 · Cited by 40
Self-citationCimini, F. A., Arena, A., Barchetta, I., Tramutola, A., Ceccarelli, V., Lanzillotta, C., Fontana, M., Bertoccini, L., Leonetti, F., Capoccia, D., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.02.021 · Cited by 39
Self-citationComprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Singh, M. K., Shin, Y., Ju, S., Han, S., Kim, S. S., & Kang, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136901 · Cited by 43
Miralem, T., Lerner‐Marmarosh, N., Gibbs, P., Jenkins, J. L., Heimiller, C., & Maines, M. D. (2016) · The FASEB Journal · doi:10.1096/fj.201600330rr · Cited by 38
Heme Oxygenase-1 in Central Nervous System Malignancies
Sferrazzo, G., Rosa, M. D., Barone, E., Volti, G. L., Musso, N., Tibullo, D., & Barbagallo, I. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051562 · Cited by 36
Self-citationThe Role of Bilirubin and the Other “Yellow Players” in Neurodegenerative Diseases
Jayanti, S. D., Vı́tek, L., Tiribelli, C., & Gazzin, S. (2020) · Antioxidants · doi:10.3390/antiox9090900 · Cited by 38
Ammonia-induced miRNA expression changes in cultured rat astrocytes
Oenarto, J., Karababa, A., Castoldi, M., Bidmon, H. J., Görg, B., & Häussinger, D. (2016) · Scientific Reports · doi:10.1038/srep18493 · Cited by 35
Wang, L., Yokoyama, K. K., Lin, C., Chen, T.-Y., Hsiao, H.-W., Chiang, P.-C., & Hsu, C. (2016) · Scientific Reports · doi:10.1038/srep26358 · Cited by 34
Cerebrospinal fluid analysis in Alzheimer’s disease: technical issues and future developments
Lista, S., Zetterberg, H., Dubois, B., Blennow, K., & Hampel, H. J. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7366-z · Cited by 34
Ge, X., Liu, Z., Hou, Q., Huang, L., Zhou, Y., Li, D., Huang, S., Luo, X., Lv, Y., Li, L., et al. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113683 · Cited by 32
Bilirubin and inflammation in neurodegenerative and other neurological diseases
Jayanti, S. D., Moretti, R., Tiribelli, C., & Gazzin, S. (2020) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2019.14 · Cited by 33
Kurucz, A., Bombicz, M., Kiss, R., Priksz, D., Varga, B., Hortobágyi, T., Trencsényi, G., Szabó, R., Pósa, A., Gesztelyi, R., et al. (2018) · BioMed Research International · doi:10.1155/2018/7212861 · Cited by 32
Huang, S., Meng, N., Liu, Z., Guo, L., Dong, L., Li, B., & Ye, Q. (2018) · Nutrients · doi:10.3390/nu10070926 · Cited by 31
The compensatory antioxidant response system with a focus on neuroprogressive disorders
Morris, G., Puri, B. K., Walker, A. J., Berk, M., Walder, K. R., Bortolasci, C. C., Marx, W., Carvalho, A. F., & Maes, M. H. J. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109708 · Cited by 33
Sung, H. Y., Choi, B., Jeong, J. H., Kong, K. A., Hwang, J., & Ahn, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153156 · Cited by 30
Insulin resistance in Alzheimer disease: Is heme oxygenase-1 an Achille's heel?
Barone, E., & Butterfield, D. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.013 · Cited by 30
Self-citationLanzillotta, C., Tramutola, A., Lanzillotta, S., Greco, V., Pagnotta, S. E., Sanchini, C., Angelantonio, S. D., Forte, E., Rinaldo, S., Paone, A., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103221 · Cited by 30
Self-citationAli, T. A., Mohamed, G. G., & Farag, A. H. (2015) · International Journal of Electrochemical Science · doi:10.1016/s1452-3981(23)05014-9 · Cited by 29
Sun, L. V., Zhang, J., Chen, W., Chen, Y., Zhang, X., Yang, M., Xiao, M., Ma, F., Yao, Y., Ye, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13210 · Cited by 23
The Emerging Role of Ferroptosis in Sepsis, Opportunity or Challenge?
Huang, Q., Ding, Y., Fang, C., Wang, H., & Kong, L. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s419993 · Cited by 28
Bhardwaj, M., Deshmukh, R. R., Kaundal, M., & Reddy, B. V. K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.037 · Cited by 27
Bilirubin and Redox Stress in Age-Related Brain Diseases
Llido, J. P., Jayanti, S. D., Tiribelli, C., & Gazzin, S. (2023) · Antioxidants · doi:10.3390/antiox12081525 · Cited by 27
Heath, L. M., Earls, J. C., Magis, A. T., Kornilov, S. A., Lovejoy, J. C., Funk, C. C., Rappaport, N., Logsdon, B. A., Mangravite, L. M., Kunkle, B. W., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09825-2 · Cited by 26
Chen, L., Chang, S., Zhao, L., Li, B., Zhang, S., Yun, C., Wu, X. M., Meng, J., Li, G., Guo, S., et al. (2022) · Microbial Biotechnology · doi:10.1111/1751-7915.14095 · Cited by 24
Acrocomia aculeata(Jacq.) Lodd. ex Mart. Leaves Increase SIRT1 Levels and Improve Stress Resistance
Monteiro‐Alfredo, T., Matafome, P. N., Iacia, B. P., Antunes, K. Á., dos Santos, J. M., da Cunha, J. D. S. M., Oliveira, S., Oliveira, A. S., Campos, J. F., Magalhães, M., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5238650 · Cited by 23
Bilirubin: A Promising Therapy for Parkinson’s Disease
Jayanti, S. D., Moretti, R., Tiribelli, C., & Gazzin, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126223 · Cited by 23
Mumtaz, I., Ayaz, M. O., Khan, M. S., Manzoor, U., Ganayee, M. A., Bhat, A. Q., Dar, G. H., Alghamdi, B. S. A., Hashem, A. M., Dar, M. J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.977411 · Cited by 23
Takemoto, J. Y., Chang, C. T., Chen, D., & Hinton, G. W. (2019) · Israel Journal of Chemistry · doi:10.1002/ijch.201800167 · Cited by 22
Neuroprotective Roles of the Biliverdin Reductase-A/Bilirubin Axis in the Brain
Paul, B. D., & Pieper, A. A. (2024) · Biomolecules · doi:10.3390/biom14020155 · Cited by 21
Lanzillotta, C., Zuliani, I., Vasavda, C., Snyder, S. H., Paul, B. D., Marzia Perluigi, A., Domenico, F. D., & Barone, E. (2020) · Antioxidants · doi:10.3390/antiox9080671 · Cited by 23
Self-citationLi, C., Cui, K., Zhu, X., Wang, S., Yang, Q., & Fang, G. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1453582 · Cited by 22
Zhou, J., Terluk, M. R., Basso, L. M., Mishra, U. R., Orchard, P. J., Cloyd, J. C., Schröder, H., & Kartha, R. V. (2020) · Biomedicines · doi:10.3390/biomedicines8080240 · Cited by 20
Barone, E., Cenini, G., Domenico, F. D., Noel, T., Wang, C., Perluigi, M., Clair, D. S., & Butterfield, D. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23627 · Cited by 18
Self-citationHeme oxygenase-1 induction by hemin prevents oxidative stress-induced acute cholestasis in the rat
Martín, P. L., Ceccatto, P., Razori, M. V., Francés, D. E., Arriaga, S. M. M., Pisani, G. B., Martínez, A. I., Pozzi, E. J. S., Roma, M. G., & Basiglio, C. L. (2018) · Clinical Science · doi:10.1042/cs20180675 · Cited by 19
Ginseng and heme oxygenase-1: The link between an old herb and a new protective system
Carota, G., Raffaele, M., Sorrenti, V., Salerno, L., Pittalà, V., & Intagliata, S. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.104370 · Cited by 19
Ceccarelli, V., Barchetta, I., Cimini, F. A., Bertoccini, L., Chiappetta, C., Capoccia, D., Carletti, R., Cristofano, C. D., Silecchia, G., Fontana, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239091 · Cited by 19
Self-citationButterfield, D. A., Debra Boyd-kimball, A., & Reed, T. T. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0214 · Cited by 20
Self-citationMounier, N. M., Wahdan, S. A., Gad, A. M., & Azab, S. S. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02081-7 · Cited by 18
RetractedKataura, T., Saiki, S., Ishikawa, K., Akamatsu, W., Sasazawa, Y., Hattori, N., & Imoto, M. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14997 · Cited by 17
RGFP966 exerts neuroprotective effect via HDAC3/Nrf2 pathway after surgical brain injury in rats
Gu, H.-P., Wu, X.-F., Gong, Y., Wu, M., Shi, M.-Y., Sun, Y.-M., Dang, B., & Chen, G. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18160 · Cited by 16
Cimini, F. A., Marzia Perluigi, A., Barchetta, I., Cavallo, M. G., & Barone, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105574 · Cited by 17
Self-citationAssociation between serum bilirubin concentration and Parkinson's disease: a meta-analysis
Jin, J., Liu, X., Li, M., Bai, X., & Xie, A. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001300 · Cited by 13
Cimini, F. A., Barchetta, I., Zuliani, I., Pagnotta, S. E., Bertoccini, L., Dule, S., Zampieri, M., Reale, A., Baroni, M. G., Cavallo, M. G., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119913 · Cited by 13
Self-citationResearch progress on the biosynthesis, activity and application of natural tetrapyrrole compounds
Hu, M., Lu, X., Qin, S., Liu, R., Wang, Q., Lu, C., & Li, W. (2024) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2024.105736 · Cited by 12
Bilirubin neurotoxicity: a narrative review on long lasting, insidious, and dangerous effects
Brites, D. M. T. O., & Silva, R. F. M. (2021) · Pediatric Medicine · doi:10.21037/pm-21-37 · Cited by 13
Kim, J., Cho, C. H., Hahn, H., Choi, S., & Cho, S. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.10.010 · Cited by 12
Mhillaj, E., Cuomo, V., & Mancuso, C. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000296 · Cited by 11
Self-citationXing, S., Shen, D., Chen, C., Wu, B., & Chi, H. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4732 · Cited by 11
Amyloid β perturbs elevated heme flux induced with neuronal development
Vidal, C., Daescu, K., FitzGerald, K. E., Starokadomska, A., Борисович, Б. И., & Li, Z. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.12.003 · Cited by 11
Metadata
- Authors
- Barone, E., Di Domenico, F., Mancuso, C., & Butterfield, D. A.
- Affiliations
- University of Kentucky (US)
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Butterfield, D. Allan
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 62
- Pages
- 144-159
- ISSN
- 0969-9961 (ISSN-L)
- PMC
- PMC3877707
- OpenAlex
- W2082990108
- Cited by
- 127
- References
- 227
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 15 · 2019: 12 · 2018: 10 · 2017: 8 · 2016: 8 · 2015: 18 · 2014: 11
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- NIH (AG-05119)
- Fondi Ateneo
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, heme oxygenase-1, biliverdin reductase A, biliverdin, bilirubin, carbon monoxide, ferrous iron, oxidative stress, nitrosative stress, neuroprotection, neurotoxicity, amnestic mild cognitive impairment, post-translational modification, stress response
- MeSH terms
- Alzheimer Disease, Animals, Brain, Heme Oxygenase (Decyclizing), Humans, Models, Neurological, Oxidative Stress, Oxidoreductases Acting on CH-CH Group Donors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
